New drug target for inflammatory disease is all the RAGE

December 21, 2016
Credit: Mary Ann Liebert, Inc., publishers

Researchers have shown that Receptor for Advanced Glycation End Products (RAGE) helps to regulate a key signaling pathway known to promote both acute and chronic inflammation. The development of therapeutic drugs targeted to RAGE could be used to treat a range of inflammatory diseases such as asthma, infection, atherosclerosis, and arthritis, as described in an article in DNA and Cell Biology.

In "Receptor for Advanced Glycation End Products (RAGE) Regulates Leukotriene B4 Receptor 1 Signaling," authors Takako Ichiki Tomoaki Koga, and Takehiko Yokomizo, Juntendo University School of Medicine, Tokyo, and Kumamoto University, Kumamoto, Japan, report how they observed that RAGE binds to the leukotriene B4 receptor 1 (BLT1) receptor. This interaction between RAGE and BLT1 modifies LTB4-BLT1 signaling, which modulates the inflammatory response through its effects on cell migration.

"RAGE is an alarmin, a molecule that alerts the host of potential risks and challenges. It is induced in or diseases and promotes more inflammation," says Carol Shoshkes Reiss, PhD, Editor-in-Chief, of DNA and Cell Biology and Professor, Departments of Biology and Neural Science, and Global Public Health at New York University, NY. "By developing new drugs to block the interaction of RAGE with its receptor, in the future, there may be treatments of some aspects of these diseases."

Explore further: The beta-1 adrenergic receptor and RAGE work together to break hearts

More information: Takako Ichiki et al, Receptor for Advanced Glycation End Products Regulates Leukotriene BReceptor 1 Signaling, DNA and Cell Biology (2016). DOI: 10.1089/dna.2016.3552

Related Stories

Rage against the disease

August 5, 2013

Imagine a world where asthma wasn't a chronic disease, rather an inconvenient illness whose first symptoms could be easily treated. This vision could one day become a reality thanks to cutting-edge research into an immune ...

Recommended for you

Researchers find molecular trigger for brain inflammation

April 27, 2017

Brain inflammation is a key component of multiple sclerosis, Alzheimer's, Parkinson's, ALS, and most other major neurodegenerative diseases. How inflammation starts, how it's sustained, and how it contributes to these diseases ...

Bitter taste receptors hold key to treating asthma

April 27, 2017

One in nine Australians, among more than 300 million people worldwide, suffer from asthma. They experience a wide range of debilitating, even life-threatening respiratory symptoms from a disease that can be controlled but ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.